Document Detail


Immediate postabortal insertion of intrauterine devices.
MedLine Citation:
PMID:  20556754     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Insertion of an intrauterine device (IUD) immediately after an abortion has several advantages. The woman is known not to be pregnant. Many clinicians refuse to insert an IUD in a woman who is not menstruating. After induced abortion, a woman's motivation to use contraception may be high. However, insertion of an IUD immediately after a pregnancy ends carries risks, such as spontaneous expulsion due to recent cervical dilation. OBJECTIVES: To assess the safety and efficacy of IUD insertion immediately after spontaneous or induced abortion. SEARCH STRATEGY: We searched MEDLINE, CENTRAL, POPLINE, EMBASE, ClinicalTrials.gov, and ICTRP. We also contacted investigators to identify other trials. SELECTION CRITERIA: We sought all randomized controlled trials with at least one treatment arm that involved IUD insertion immediately after an induced abortion or after curettage for spontaneous abortion. We identified 11 trials which described random assignment. DATA COLLECTION AND ANALYSIS: We evaluated the methodological quality of each report and abstracted the data. We focused on discontinuation rates for accidental pregnancy, perforation, expulsion, and pelvic inflammatory disease. We computed the weighted average of the rate ratios. We computed relative risks (RR) with 95% Confidence Intervals (CI). MAIN RESULTS: Three trials randomized to immediate or delayed insertion. One showed no significant differences. Meta-analysis of two showed use of levonorgestrel-releasing intrauterine system or CuT380A was more likely for immediate versus delayed insertion (RR 1.18; 95% CI 1.08 to 1.28). Another trial randomized to the levonorgestrel IUD or Nova T; discontinuation rates due to pregnancy were 0.8 and 9.5, respectively. Sub-analysis showed higher expulsion rates for postabortal than interval insertions (levonorgestrel: 2.8 versus 6.8; Nova T: 3.0 versus 8.3).Seven trials examined immediate insertion. From meta-analysis of two multicenter trials, pregnancy was less likely for the TCu 220C versus the Lippes Loop (RR 0.38; 95% CI 0.20 to 0.72) as was expulsion (RR 0.51; 95% CI 0.30 to 0.88). Estimates for the TCu 220 versus the Copper 7 were 0.52 (95% CI 0.36 to 0.77) and 0.58 (95% CI 0.39 to 0.87), respectively. In other work, adding copper sleeves to the Lippes Loop improved efficacy (RR 3.82; 95% CI 1.41 to 10.36) and reduced expulsion (RR 3.37; 95% CI 1.65 to 6.90). AUTHORS' CONCLUSIONS: Insertion of an IUD immediately after abortion is safe and practical. IUD expulsion rates appear higher than after interval insertions. However, IUD use is higher at six months with immediate than with interval insertion.
Authors:
David A Grimes; Laureen M Lopez; Kenneth F Schulz; Nancy L Stanwood
Related Documents :
8709884 - Oral retinoids and pregnancy.
8661644 - Occlusion of the neonatal patent ductus arteriosus with a simple retrievable device: a ...
1135704 - Lynestrenol as a contraceptive preparation. experience with a micro-dosage formulation.
12204784 - Contraceptive failure--results from a study conducted among women with accepted and una...
1407924 - Prenatal diagnosis of dilated cava septi pellucidi et vergae: associated anomalies, dif...
19839754 - Mthfr c677t and factor v leiden in recurrent pregnancy loss: a study among an endogamou...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2010-06-16
Journal Detail:
Title:  Cochrane database of systematic reviews (Online)     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2010  
Date Detail:
Created Date:  2010-06-17     Completed Date:  2010-07-27     Revised Date:  2010-10-21    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD001777     Citation Subset:  IM    
Affiliation:
Behavioral and Biomedical Research, Family Health International, P.O. Box 13950, Research Triangle Park, North Carolina, USA, 27709.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Induced*
Abortion, Spontaneous*
Female
Humans
Intrauterine Device Expulsion
Intrauterine Devices*
Intrauterine Devices, Copper
Intrauterine Devices, Medicated
Levonorgestrel
Pregnancy
Randomized Controlled Trials as Topic
Time Factors
Chemical
Reg. No./Substance:
797-63-7/Levonorgestrel
Comments/Corrections
Update Of:
Cochrane Database Syst Rev. 2004;(4):CD001777   [PMID:  15495018 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arthroplasties (with and without bone cement) for proximal femoral fractures in adults.
Next Document:  Intravenous immunoglobulin for Guillain-Barr? syndrome.